tirzepatide shortage 2025 Important Notice: Compounding Update FDA sets tirzepatide compounding deadlines

Weeks 1-4 Starting dose Weeks 5-8 First increase Weeks 9-12 Therapeutic level Weeks 13-16 Near target Week 17+ Full dose Side Effects & Safety Most side effects are mild, temporary, and occur during dose increases

If you can access and afford branded semaglutide (Ozempic or Wegovy), it offers the highest quality assurance backed by FDA approval and clinical trials

Clinical data asks a harder question: what happens after months of treatment, structured follow-up, adverse-event tracking, and statistical comparison with placebo

While many people follow the once-weekly schedule without issue, others encounter hurdles that make dose splitting an attractive conversation for their doctor